zk 112993 has been researched along with Experimental Mammary Neoplasms in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Archer, TK; Mymryk, JS | 1 |
Gehring, S; Kühnel, W; Michna, H; Nishino, Y; Schneider, MR | 1 |
el Etreby, MF; McGuire, WL; Michna, H; Nishino, Y; Schneider, M | 1 |
el Etreby, MF; Michna, H; Nishino, Y; Schneider, MR | 1 |
4 other study(ies) available for zk 112993 and Experimental Mammary Neoplasms
Article | Year |
---|---|
Influence of hormone antagonists on chromatin remodeling and transcription factor binding to the mouse mammary tumor virus promoter in vivo.
Topics: Animals; Binding, Competitive; Chromatin; Dexamethasone; Glucocorticoids; Gonanes; Hormone Antagonists; Mammary Neoplasms, Experimental; Mammary Tumor Virus, Mouse; Mice; Mifepristone; Promoter Regions, Genetic; Receptors, Glucocorticoid; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 1995 |
The antitumor potency of progesterone antagonists is due to their differentiation potential.
Topics: Animals; Antineoplastic Agents; Cell Differentiation; Gonanes; Mammary Neoplasms, Experimental; Mice; Mifepristone; Progesterone; Rats | 1992 |
Progesterone antagonists block the growth of experimental mammary tumors in G0/G1.
Topics: Animals; Antineoplastic Agents; Cell Division; Female; G1 Phase; Gonanes; Mammary Neoplasms, Experimental; Mifepristone; Progesterone; Rats; Rats, Inbred Strains; Resting Phase, Cell Cycle | 1990 |
The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death.
Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line; Cell Survival; Estradiol; Female; Gonanes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Mifepristone; Ovariectomy; Progesterone; Tumor Cells, Cultured | 1989 |